Literature DB >> 16785234

Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death.

Dongmei Lu1, Jie Huang, Alakananda Basu.   

Abstract

We have previously shown that protein kinase Cepsilon (PKCepsilon) protects breast cancer cells from tumor necrosis factor-alpha (TNF)-induced cell death. In the present study, we have investigated if the antiapoptotic function of PKCepsilon is mediated via Akt and the mechanism by which PKCepsilon regulates Akt activity. TNF caused a transient increase in Akt phosphorylation at Ser473 in MCF-7 cells. Overexpression of PKCepsilon in MCF-7 cells increased TNF-induced Akt phosphorylation at Ser473 resulting in its activation. Knockdown of PKCepsilon by small interfering RNA (siRNA) decreased TNF-induced Akt phosphorylation/activation and increased cell death. Introduction of constitutively active Akt protected breast cancer MCF-7 cells from TNF-mediated cell death and partially restored cell survival in PKCepsilon-depleted cells. Depletion of Akt in MCF-7 cells abolished the antiapoptotic effect of PKCepsilon on TNF-mediated cell death. Akt was constitutively associated with PKCepsilon and DNA-dependent protein kinase (DNA-PK), and this association was increased by TNF treatment. Overexpression of PKCepsilon enhanced the interaction between Akt and DNA-PK. Knockdown of DNA-PK by siRNA inhibited TNF-induced Akt phosphorylation and the antiapoptotic effect of Akt and PKCepsilon. These results suggest that PKCepsilon activates Akt via DNA-PK to mediate its antiapoptotic function. Furthermore, we report for the first time that DNA-PK can regulate receptor-initiated apoptosis via Akt.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785234     DOI: 10.1074/jbc.M603390200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.

Authors:  Si Ming Man; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

2.  Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB.

Authors:  Wei-Chien Huang; Tsai-Kai Ju; Mien-Chie Hung; Ching-Chow Chen
Journal:  Mol Cell       Date:  2007-04-13       Impact factor: 17.970

3.  Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.

Authors:  Jian Ma; Yan Ding; Xianfeng Fang; Ruiqing Wang; Zuoming Sun
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

4.  Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2.

Authors:  Alakananda Basu; Savitha Sridharan; Shalini Persaud
Journal:  Cell Signal       Date:  2009-07-23       Impact factor: 4.315

5.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.

Authors:  Gianmaria Liccardi; John A Hartley; Daniel Hochhauser
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 6.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

7.  BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.

Authors:  Supriya Gaitonde; Surya K De; Marianna Tcherpakov; Antimone Dewing; Hongbin Yuan; Megan Riel-Mehan; Stan Krajewski; Gavin Robertson; Maurizio Pellecchia; Ze'ev Ronai
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-17       Impact factor: 4.693

8.  Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.

Authors:  Yikun Li; Xuerong Wang; Ping Yue; Hui Tao; Suresh S Ramalingam; Taofeek K Owonikoko; Xingming Deng; Ya Wang; Haian Fu; Fadlo R Khuri; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

9.  PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.

Authors:  Dongcheng Wu; Fangfang Peng; Baifang Zhang; Alistair J Ingram; Darren J Kelly; Richard E Gilbert; Bo Gao; Joan C Krepinsky
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

10.  Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells.

Authors:  Boon Tin Chua; David Gallego-Ortega; Ana Ramirez de Molina; Axel Ullrich; Juan Carlos Lacal; Julian Downward
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.